Rodney P Rocconi

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. doi request reprint Lipoxygenase pathway receptor expression in ovarian cancer
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36607, USA
    Reprod Sci 15:321-6. 2008
  2. ncbi request reprint Primary lung large cell carcinoma metastatic to the vulva: a case report and review of the literature
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Gynecol Oncol 94:829-31. 2004
  3. ncbi request reprint Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)
    Rodney P Rocconi
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Gynecol Oncol 105:113-21. 2007
  4. ncbi request reprint Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy
    Rodney P Rocconi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 20th Street South, Old Hillman Building Room 538, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 103:985-9. 2006
  5. ncbi request reprint Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis
    Rodney P Rocconi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Cancer 107:536-43. 2006
  6. ncbi request reprint Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rodney P Rocconi
    University of Alabama at Birmingham, 35233, USA
    Oncologist 11:336-41. 2006
  7. ncbi request reprint Targeted gene therapy for ovarian cancer
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Curr Gene Ther 5:643-53. 2005
  8. ncbi request reprint Management strategies for abnormal early pregnancy: a cost-effectiveness analysis
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham 35233, USA
    J Reprod Med 50:486-90. 2005
  9. ncbi request reprint Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 97:387-94. 2005
  10. ncbi request reprint The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rodney P Rocconi
    Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA
    Gynecol Oncol 114:242-5. 2009

Detail Information

Publications38

  1. doi request reprint Lipoxygenase pathway receptor expression in ovarian cancer
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36607, USA
    Reprod Sci 15:321-6. 2008
    ..To determine the expression of lipoxygenase (LOX) pathway receptors in ovarian cancer as a potential target for anti-LOX-based therapy...
  2. ncbi request reprint Primary lung large cell carcinoma metastatic to the vulva: a case report and review of the literature
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Gynecol Oncol 94:829-31. 2004
    ..Metastatic cancer to the vulva is a rare diagnosis and is estimated to account for 5-8% of all vulvar cancers...
  3. ncbi request reprint Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)
    Rodney P Rocconi
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Gynecol Oncol 105:113-21. 2007
    ..In an effort to circumvent these limitations, we evaluated various CRAds modified to incorporate novel capsid targeting motifs (RGD and chimeric Ad5/3) with a novel tissue-specific promoter (CXCR4)...
  4. ncbi request reprint Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy
    Rodney P Rocconi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 20th Street South, Old Hillman Building Room 538, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 103:985-9. 2006
    ..In an animal model of ovarian cancer, we explored whether a survival advantage exists utilizing icodextrin rather than PBS as a delivery solution for an infectivity enhanced virotherapy approach...
  5. ncbi request reprint Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis
    Rodney P Rocconi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Cancer 107:536-43. 2006
    ..Therefore, the objective in the current study was to assess the cost-effectiveness of salvage chemotherapy for patients with platinum-resistant epithelial ovarian cancer (EOC)...
  6. ncbi request reprint Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rodney P Rocconi
    University of Alabama at Birmingham, 35233, USA
    Oncologist 11:336-41. 2006
    ....
  7. ncbi request reprint Targeted gene therapy for ovarian cancer
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Curr Gene Ther 5:643-53. 2005
    ..Due to the advancements in detection and targeting of ovarian cancer, coupled with the containment to the intraperitoneal cavity, gene therapy remains a promising treatment modality for ovarian cancer...
  8. ncbi request reprint Management strategies for abnormal early pregnancy: a cost-effectiveness analysis
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham 35233, USA
    J Reprod Med 50:486-90. 2005
    ..To assess the potential effectiveness and costs of 4 commonly used strategies to manage abnormal early pregnancies (AEPs)...
  9. ncbi request reprint Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 97:387-94. 2005
    ..To assess the potential effectiveness and medical costs of three common strategies to manage Stage IB2 squamous cell carcinoma of the cervix (CXCA)...
  10. ncbi request reprint The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rodney P Rocconi
    Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA
    Gynecol Oncol 114:242-5. 2009
    ..To determine if the timing of normalization of CA-125 levels during primary chemotherapy for epithelial ovarian cancer (EOC) could predict survival...
  11. ncbi request reprint Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma
    Mariam A Stoff-Khalili
    Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, 901 19th Street South, BMR2 502, Birmingham, AL 35294 2172, USA
    Breast Cancer Res Treat 105:157-67. 2007
    ..The present study addresses the utility of human mesenchymal stem cells (hMSCs) as intermediate carriers for conditionally replicating adenoviruses (CRAds) to target metastatic breast cancer in vivo...
  12. ncbi request reprint Gene therapy for ovarian cancer
    Kristopher J Kimball
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Curr Oncol Rep 8:441-7. 2006
    ..We highlight the most recent advances in these novel therapeutic approaches for ovarian cancer and include a summary of recent clinical trials...
  13. ncbi request reprint Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer
    Mariam A Stoff-Khalili
    Division of Human Gene Therapy, Department of Medicine and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Int J Cancer 120:935-41. 2007
    ..In conclusion, utilization of a CRAd that combined infectivity enhancement strategies and transcriptional targeting improved the CRAd-based antineoplastic effects for breast cancer therapy...
  14. ncbi request reprint Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy
    Jacob M Estes
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama Birmingham, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Am Coll Surg 203:527-32. 2006
    ..Our goal was to determine the morbidity, disease-free survival, and overall survival of patients with bowel resection at primary cytoreductive surgery for advanced epithelial ovarian carcinoma in the era of platinum and taxane chemotherapy...
  15. ncbi request reprint A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer
    Ashley S Case
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, USA
    Gynecol Oncol 105:223-7. 2007
    ..Therefore, our goal was to assess the effectiveness and medical costs of chemotherapy for platinum-sensitive patients with advanced EOC...
  16. doi request reprint The effect of obesity on survival in patients with ovarian cancer
    Kellie S Matthews
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Gynecol Oncol 112:389-93. 2009
    ..We sought to determine if obesity portends a disadvantage to surgical outcomes at the time of initial surgery affecting survival...
  17. ncbi request reprint Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary
    Kathleen N Moore
    University of Oklahoma, Division of Gynecologic Oncology, 920 SL Young Blvd, Oklahoma City, OK 73104, USA
    Gynecol Oncol 107:398-403. 2007
    ..Primary carcinoma of the fallopian tube (PCFT) is a rare malignancy comprising 1% of genital tract cancers. We sought to compare survival trends between PCFT and ovarian carcinoma (OC) patients (pts) in a matched, case-control comparison...
  18. pmc A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway
    Yuko Tsuruta
    Division of Human Gene Therapy, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama 35294 2172, USA
    Clin Cancer Res 13:2777-83. 2007
    ..We hypothesized that combined use of unique chimeric fibers in the context of novel mosaic adenovirus vectors would enhance infectivity via non-CAR pathways in ovarian cancer cells...
  19. ncbi request reprint Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    Int J Gynecol Cancer 19:888-91. 2009
    ..Because most patients will recur distantly, systemic chemotherapy should be considered for patients with early stage uterine carcinosarcoma...
  20. ncbi request reprint Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia?
    Kellie S Matthews
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    J Low Genit Tract Dis 11:69-72. 2007
    ..Our objective was to determine the incidence of cervical intraepithelial neoplasia (CIN) 2,3 and patient factors that increase the likelihood of detecting CIN 2,3...
  21. ncbi request reprint Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients
    Rodney P Rocconi
    Division of Gynecologic Oncology, University of South Alabama Mitchell Cancer Institute, 1 Mobile Infirmary Circle, 1st Floor, Mobile, AL 36607, USA
    Gynecol Oncol 108:336-41. 2008
    ..Thus, the aim of this study was to evaluate the association of relative chemotherapy-induced neutropenia with survival in advanced epithelial ovarian cancer (EOC)...
  22. pmc Lynch syndrome in women less than 50 years of age with endometrial cancer
    Kellie S Matthews
    Division of Gynecologic Oncology and the Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Obstet Gynecol 111:1161-6. 2008
    ..To estimate the frequency of mismatch repair deficiencies associated with hereditary nonpolyposis colorectal cancer, or Lynch syndrome, in women less than age 50 with endometrial cancer...
  23. ncbi request reprint A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer
    Ashley S Case
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
    Obstet Gynecol 108:1375-9. 2006
    ..To prospectively evaluate in a blinded fashion the accuracy of frozen section in endometrial cancer...
  24. ncbi request reprint Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy
    Tyler O Kirby
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, OHB 538, 619 19th Street South, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 98:309-12. 2005
    ..To investigate the patterns of recurrence associated with superficial inguinal lymphadenectomy (SupIL) and vulvectomy for patients with Stage I/II vulvar cancer...
  25. doi request reprint Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of South Alabama Mitchell Cancer Institute, Mobile, Alabama 36607, USA
    Reprod Sci 15:673-7. 2008
    ..This study aimed at evaluating the expression of tyrosine kinase receptors c-kit, (platelet-derived growth factor receptor-alpha (PDGFR-alpha), and PDGFR-beta in ovarian granulosa cell tumors (GCTs)...
  26. ncbi request reprint The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
    T Michael Numnum
    University of Alabama at Birmingham, 619 19th Street South, OHB 538, Birmingham, AL 35294, USA
    Gynecol Oncol 102:425-8. 2006
    ..To evaluate our experience with the use of bevacizumab in patients with heavily pretreated recurrent ovarian carcinoma who have symptomatic ascites...
  27. ncbi request reprint Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system
    Mariam A Stoff-Khalili
    Division of Human Gene Therapy, Department of Medicine and Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Cancer Biol Ther 4:1203-10. 2005
    ..These preclinical results suggest that Ad5/3 is the most useful modification to achieve higher clinical efficacy of breast cancer gene therapy and virotherapy...
  28. ncbi request reprint Recurrence of endometrial adenocarcinoma in a prior Bartholin's cyst marsupialization incision
    Kimberly Ray
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 103:749-51. 2006
    ..Endometrial cancer recurrences in surgical incisions are rare and thought to be due to seeding of the area with microscopic disease at the time of original surgery...
  29. doi request reprint Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?
    Jenny M Whitworth
    Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL, USA
    Int J Gynecol Cancer 21:1131-4. 2011
    ..We sought to determine the effectiveness and adverse effects of a preoperative dose of anticoagulation in patients with gynecologic oncology...
  30. ncbi request reprint Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report
    Whitney A Spannuth
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 619 19th Street South, Old Hillman Building Room 538, Birmingham, AL 35294 7333, USA
    Gynecol Oncol 98:155-7. 2005
    ..Although mature cystic teratoma is the most common tumor of the ovary, squamous cell carcinoma arising from a mature teratoma is a rare event. Prognosis depends on clinical stage, grade, and recently described mode of tumor infiltration...
  31. ncbi request reprint A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic masses
    Whitney A Spannuth
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 619 19th Street South, Old Hillman Building Room 538, Birmingham, AL 35294 7333, USA
    Gynecol Oncol 99:443-6. 2005
    ..Our goal was to compare HALS to conventional laparotomy for pelvic masses in gynecologic patients...
  32. ncbi request reprint Unilateral cervical cancer in a patient with cervix duplex
    Kristopher J Kimball
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35249, USA
    Gynecol Oncol 103:346-8. 2006
    ..Although uterine anomalies are uncommon, gynecologists must be aware of the anatomical challenges that may be encountered from these anomalies. Cervical cancer in the context of a mullerian lateral fusion defect is rare...
  33. ncbi request reprint Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies
    Ashley S Case
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 South 19th Street, Old Hillman Building Room 549, Birmingham, AL 35233, USA
    Gynecol Oncol 101:499-502. 2006
    ..Our objective was to determine the subsequent transfusion rates following administration of either darbepoetin alfa or epoetin alfa...
  34. ncbi request reprint Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes
    Ashley S Case
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Obstet Gynecol 108:1369-74. 2006
    ..We sought to estimate the incidence of cervical intraepithelial neoplasia (CIN) and treatment outcomes in adolescents with abnormal cytology...
  35. doi request reprint Overcoming technical challenges with robotic surgery in gynecologic oncology
    Michael A Finan
    Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, 1660 Springhill Avenue, Mobile, AL 36604 1405, USA
    Surg Endosc 24:1256-60. 2010
    ..This study focuses on these technical problems and identifies pitfalls and potential solutions in robotics...
  36. ncbi request reprint Complete uterine necrosis following chemoradiation for advanced cervical cancer: a case report
    Kellie S Matthews
    University of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL 35249, USA
    Gynecol Oncol 106:265-7. 2007
    ..Although generally transient, complications of radiation therapy can become severe and require further intervention. Uterine necrosis is uncommon and the management can be complex...
  37. doi request reprint Vaginal cancer: the experience from 2 large academic centers during a 15-year period
    Camille C Gunderson
    1Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Oklahoma, Oklahoma City, OK and 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL
    J Low Genit Tract Dis 17:409-13. 2013
    ..Limited data regarding the natural history, management, and prognosis of vaginal cancer exist owing to the relative disease rarity...
  38. ncbi request reprint A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
    Kathleen N Moore
    University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd WP 2470, Oklahoma City, OK 73014, and Washington University Barnes Jewish Christian Hospitals, St Louis, MO, USA
    Gynecol Oncol 105:299-303. 2007
    ..The objective of this study was to compare response rate and survival in patients with cervical cancer treated with PT or CT...